Johnson Pharmacare Ltd Financial Ratios
JOHNPHARMA · Commercial Services · Current price ₹0.4
P/E ratio
-0.4x
P/B ratio
57.5x
ROE
-1.0%
ROCE
-1.0%
Debt / Equity
49.18
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | -0.4x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 57.5x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | -1.0% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | -1.0% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 49.18 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Johnson Pharmacare Ltd's latest numbers.
Johnson Pharmacare Ltd profitability
Johnson Pharmacare Ltd generates a return on equity of -1.0% and a return on capital employed of -1.0%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 49.18 and a P/E of -0.4x, Johnson Pharmacare Ltd is carrying meaningful debt. Our overall business-quality score for the company is 2.2 / 10.
Understand the ratios
More on Johnson Pharmacare Ltd
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.